Clinical Trial Update: Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating target attainment of continuous infusion flucloxacillin and cefazolin with therapeutic drug monitoring versus standard …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infections

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• flucloxacillin (flucloxacillin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) | Phase 2 | Status: RECRUITING